Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 55

    1.

    Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study.

    Boot BP, Boeve BF, Roberts RO, Ferman TJ, Geda YE, Pankratz VS, Ivnik RJ, Smith GE, McDade E, Christianson TJ, Knopman DS, Tangalos EG, Silber MH, Petersen RC.

    Ann Neurol. 2012 Jan;71(1):49-56. doi: 10.1002/ana.22655.

    PMID:
    22275251
    [PubMed - indexed for MEDLINE]
    2.

    Head injury, α-synuclein Rep1, and Parkinson's disease.

    Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM.

    Ann Neurol. 2012 Jan;71(1):40-8. doi: 10.1002/ana.22499.

    PMID:
    22275250
    [PubMed - indexed for MEDLINE]
    3.

    Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.

    van Es MA, Schelhaas HJ, van Vught PW, Ticozzi N, Andersen PM, Groen EJ, Schulte C, Blauw HM, Koppers M, Diekstra FP, Fumoto K, LeClerc AL, Keagle P, Bloem BR, Scheffer H, van Nuenen BF, van Blitterswijk M, van Rheenen W, Wills AM, Lowe PP, Hu GF, Yu W, Kishikawa H, Wu D, Folkerth RD, Mariani C, Goldwurm S, Pezzoli G, Van Damme P, Lemmens R, Dahlberg C, Birve A, Fernández-Santiago R, Waibel S, Klein C, Weber M, van der Kooi AJ, de Visser M, Verbaan D, van Hilten JJ, Heutink P, Hennekam EA, Cuppen E, Berg D, Brown RH Jr, Silani V, Gasser T, Ludolph AC, Robberecht W, Ophoff RA, Veldink JH, Pasterkamp RJ, de Bakker PI, Landers JE, van de Warrenburg BP, van den Berg LH.

    Ann Neurol. 2011 Dec;70(6):964-73. doi: 10.1002/ana.22611. Review.

    PMID:
    22190368
    [PubMed - indexed for MEDLINE]
    4.

    Solvent exposures and parkinson disease risk in twins.

    Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, Comyns K, Korell M, Chade AR, Kasten M, Priestley B, Chou KL, Fernandez HH, Cambi F, Langston JW, Tanner CM.

    Ann Neurol. 2011 Nov 14. doi: 10.1002/ana.22629. [Epub ahead of print]

    PMID:
    22083847
    [PubMed - as supplied by publisher]
    5.

    Therapies for dopaminergic-induced dyskinesias in Parkinson disease.

    Ponsford JR.

    Ann Neurol. 2011 Oct;70(4):667; author reply 667-8. doi: 10.1002/ana.22604. No abstract available.

    PMID:
    22028228
    [PubMed - indexed for MEDLINE]
    6.

    DJ-1 modulates the expression of Cu/Zn-superoxide dismutase-1 through the Erk1/2-Elk1 pathway in neuroprotection.

    Wang Z, Liu J, Chen S, Wang Y, Cao L, Zhang Y, Kang W, Li H, Gui Y, Chen S, Ding J.

    Ann Neurol. 2011 Oct;70(4):591-9. doi: 10.1002/ana.22514. Epub 2011 Jul 27.

    PMID:
    21796667
    [PubMed - indexed for MEDLINE]
    7.

    Stem cell technology for neurodegenerative diseases.

    Lunn JS, Sakowski SA, Hur J, Feldman EL.

    Ann Neurol. 2011 Sep;70(3):353-61. doi: 10.1002/ana.22487. Review.

    PMID:
    21905078
    [PubMed - indexed for MEDLINE]
    8.

    Open-label surgical trials for Parkinson disease: time for reconsideration.

    Alterman RL, Tagliati M, Olanow CW.

    Ann Neurol. 2011 Jul;70(1):5-8. doi: 10.1002/ana.22453. Review. No abstract available.

    PMID:
    21786295
    [PubMed - indexed for MEDLINE]
    9.

    Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration.

    Kim SR, Chen X, Oo TF, Kareva T, Yarygina O, Wang C, During M, Kholodilov N, Burke RE.

    Ann Neurol. 2011 Jul;70(1):110-20. doi: 10.1002/ana.22383. Epub 2011 Mar 17.

    PMID:
    21437936
    [PubMed - indexed for MEDLINE]
    10.

    Therapies for dopaminergic-induced dyskinesias in Parkinson disease.

    Gottwald MD, Aminoff MJ.

    Ann Neurol. 2011 Jun;69(6):919-27. doi: 10.1002/ana.22423. Review.

    PMID:
    21681795
    [PubMed - indexed for MEDLINE]
    11.

    Subthalamic neuronal firing in obsessive-compulsive disorder and Parkinson disease.

    Piallat B, Polosan M, Fraix V, Goetz L, David O, Fenoy A, Torres N, Quesada JL, Seigneuret E, Pollak P, Krack P, Bougerol T, Benabid AL, Chabardès S.

    Ann Neurol. 2011 May;69(5):793-802. doi: 10.1002/ana.22222. Epub 2010 Dec 28.

    PMID:
    21520240
    [PubMed - indexed for MEDLINE]
    12.

    Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.

    Chen-Plotkin AS, Hu WT, Siderowf A, Weintraub D, Goldmann Gross R, Hurtig HI, Xie SX, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Van Deerlin VM, Lee VM, Soares H, Trojanowski JQ.

    Ann Neurol. 2011 Apr;69(4):655-63. doi: 10.1002/ana.22271. Epub 2010 Nov 29.

    PMID:
    21520231
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse.

    Berman AE, Chan WY, Brennan AM, Reyes RC, Adler BL, Suh SW, Kauppinen TM, Edling Y, Swanson RA.

    Ann Neurol. 2011 Mar;69(3):509-20. doi: 10.1002/ana.22162. Epub 2010 Nov 23.

    PMID:
    21446024
    [PubMed - indexed for MEDLINE]
    14.

    Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.

    Cullen V, Sardi SP, Ng J, Xu YH, Sun Y, Tomlinson JJ, Kolodziej P, Kahn I, Saftig P, Woulfe J, Rochet JC, Glicksman MA, Cheng SH, Grabowski GA, Shihabuddin LS, Schlossmacher MG.

    Ann Neurol. 2011 Jun;69(6):940-53. doi: 10.1002/ana.22400. Epub 2011 Apr 6.

    PMID:
    21472771
    [PubMed - indexed for MEDLINE]
    15.

    Neuropathy in idiopathic Parkinson disease: an iatrogenic problem?

    Nolano M, Provitera V, Lanzillo B, Santoro L.

    Ann Neurol. 2011 Feb;69(2):427-8; author reply 428-9. doi: 10.1002/ana.22330. No abstract available.

    PMID:
    21387392
    [PubMed - indexed for MEDLINE]
    16.

    Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint.

    Nyholm D, Askmark H, Aquilonius SM.

    Ann Neurol. 2011 Feb;69(2):424; author reply 425. doi: 10.1002/ana.22257. No abstract available.

    PMID:
    21387388
    [PubMed - indexed for MEDLINE]
    17.

    Washed cycad flour contains β-N-methyl amino-L-alanine and may explain parkinsonism symptoms.

    Banack SA, Nunn PB, Cheng R, Bradley WG.

    Ann Neurol. 2011 Feb;69(2):423; author reply 423-4. doi: 10.1002/ana.22291. No abstract available.

    PMID:
    21387387
    [PubMed - indexed for MEDLINE]
    18.

    Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor.

    Helmich RC, Janssen MJ, Oyen WJ, Bloem BR, Toni I.

    Ann Neurol. 2011 Feb;69(2):269-81. doi: 10.1002/ana.22361.

    PMID:
    21387372
    [PubMed - indexed for MEDLINE]
    19.

    Resting tremor in Parkinson disease: is the pallidum to blame?

    Boecker H, Brooks DJ.

    Ann Neurol. 2011 Feb;69(2):229-31. doi: 10.1002/ana.22358. No abstract available.

    PMID:
    21387365
    [PubMed - indexed for MEDLINE]
    20.

    Symmetry of Parkinson's disease and REM sleep: one piece of the puzzle.

    Postuma RB, Gagnon JF.

    Ann Neurol. 2011 May;69(5):905; author reply 906. doi: 10.1002/ana.22259. Epub 2011 Jan 20. No abstract available.

    PMID:
    21254194
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk